Group 1 - The Hong Kong pharmaceutical ETF (159718) increased by 1.34% on November 26, with a trading volume of 44.50 million yuan [1] - The ETF's shares decreased by 3 million, bringing the total to 241 million shares, with an increase of 3 million shares over the last 20 trading days [1] - The latest net asset value of the ETF is 237 million yuan [1] Group 2 - The performance benchmark for the Hong Kong pharmaceutical ETF is the CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index (adjusted for exchange rates) [1] - The fund is managed by Ping An Fund Management Co., Ltd., with the fund manager being Weng Xin [1] - Since its establishment on December 16, 2021, the ETF has returned -1.43%, while the return over the past month is 0.78% [1]